We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+21.19%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.77B
AUM Growth
-$20M
Cap. Flow
-$279M
Cap. Flow %
-15.76%
Top 10 Hldgs %
16.25%
Holding
547
New
90
Increased
94
Reduced
221
Closed
118

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$22.6M
2
AGN
Allergan plc
AGN
+$19.6M
3
CPRI icon
Capri Holdings
CPRI
+$18.6M
4
DAL icon
Delta Air Lines
DAL
+$17.6M
5
NTNX icon
Nutanix
NTNX
+$17.6M

Sector Composition

Rank Sector Weight
1 Healthcare 26.83%
2 Technology 24.23%
3 Consumer Discretionary 14.95%
4 Industrials 7.4%
5 Financials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBI icon
276
MBIA
MBI
$282M
$800K 0.05%
84,046
-27,258
-24% -$268K
TRUE
277
DELISTED
TrueCar
TRUE
$800K 0.05%
120,479
-69,202
-36% -$577K
XYZ
278
Block Inc
XYZ
$48.4B
$797K 0.05%
+10,644
New +$771K
VCYT icon
279
Veracyte
VCYT
$4.44B
$783K 0.04%
31,300
+2,500
+9% +$47.7K
SPNT icon
280
SiriusPoint
SPNT
$3.01B
$773K 0.04%
+74,481
New +$792K
BANC icon
281
Banc of California
BANC
$3.21B
$741K 0.04%
53,534
-6,740
-11% -$101K
CTRL
282
DELISTED
Control4 Corporation
CTRL
$730K 0.04%
43,100
-64
-0.1% -$1.15K
TAC icon
283
TransAlta
TAC
$4.25B
$727K 0.04%
98,857
-35,120
-26% -$201K
PRTA icon
284
Prothena Corp
PRTA
$455M
$714K 0.04%
+58,903
New +$735K
PGNX
285
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$706K 0.04%
+152,200
New +$689K
NMFC icon
286
New Mountain Finance
NMFC
$649M
$703K 0.04%
51,804
+12,146
+31% +$165K
INOV
287
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$702K 0.04%
56,500
-26,811
-32% -$363K
OFG icon
288
OFG Bancorp
OFG
$2.21B
$701K 0.04%
+35,400
New +$685K
PSDO
289
DELISTED
Presidio, Inc. Common Stock
PSDO
$697K 0.04%
+47,100
New +$719K
UVE icon
290
Universal Insurance Holdings
UVE
$1.21B
$678K 0.04%
21,868
-4,332
-17% -$155K
CHEF icon
291
Chefs' Warehouse
CHEF
$3.9B
$671K 0.04%
21,623
-7,877
-27% -$258K
VFF icon
292
Village Farms International
VFF
$247M
$667K 0.04%
+47,553
New +$632K
LMNX
293
DELISTED
Luminex Corp
LMNX
$665K 0.04%
+28,885
New +$725K
TRST
294
Trustco Bank Corp NY
TRST
$978M
$644K 0.04%
16,602
-1,394
-8% -$55.2K
HZO icon
295
MarineMax
HZO
$799M
$630K 0.04%
+32,900
New +$626K
DESP
296
DELISTED
Despegar.com
DESP
$626K 0.04%
+42,000
New +$664K
KFRC icon
297
Kforce
KFRC
$1.04B
$622K 0.04%
17,700
-2,319
-12% -$80.4K
ATRC icon
298
AtriCure
ATRC
$1.89B
$617K 0.03%
23,031
-3,486
-13% -$106K
PVG
299
DELISTED
PRETIUM RESOURCES INC.
PVG
$594K 0.03%
69,451
SXC icon
300
SunCoke Energy
SXC
$765M
$589K 0.03%
69,420
+10,120
+17% +$98.3K

Similar funds

PDT Partners's Q1 2019 Portfolio in Review

As of Q1 2019, PDT Partners held 547 positions worth $1.77B, down 1.1% from $1.79B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

PDT Partners withdrew a net $279M in Q1 2019, closing 118 positions and reducing 221 holdings. Its most notable exit was Morgan Stanley, an estimated $22.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in Bristol-Myers Squibb worth $30.8M.

  • PDT Partners's largest Q1 2019 buy was Bristol-Myers Squibb: 645,994 shares worth $30.8M.
  • PDT Partners added most to Anadarko Petroleum in Q1 2019, an estimated $9.65M increase.
  • PDT Partners's biggest Q1 2019 reduction was Spark Therapeutics, Inc. Common Stock, cutting an estimated $11.6M.
  • PDT Partners fully exited Morgan Stanley in Q1 2019, selling an estimated $22.6M.
  • PDT Partners's ten largest holdings make up 16% of its $1.77B portfolio in Q1 2019.
  • PDT Partners opened 90 new positions and closed 118 in Q1 2019.
  • PDT Partners's portfolio value fell 1.1% quarter-over-quarter to $1.77B.

Based on PDT Partners's 13F filing for Q1 2019, filed 15 May 2019.